Lincolnwood, IL, United States of America

Reuben Eisenstein

This inventor holds 1 USPTO granted patent. Top assignee: Rush-Presbyterian-St. Luke's Medical Center. Active years: 1977.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reuben Eisenstein: Innovator in Tissue Invasion Inhibition

Introduction

Reuben Eisenstein is a notable inventor based in Lincolnwood, IL (US). He has made significant contributions to the field of medical science, particularly in the area of tissue invasion inhibitors. His work focuses on developing innovative solutions that can impact patient treatment and recovery.

Latest Patents

Eisenstein holds a patent for the "Preparation of tissue invasion inhibitor and method of treatment." This invention involves a composition of matter that acts as an inhibitor of cell proliferation, obtained through the aqueous extraction of tissue rich in collagen and/or proteoglycans. This patent highlights his commitment to advancing medical treatments and improving patient outcomes.

Career Highlights

Eisenstein is affiliated with Rush-Presbyterian-St. Luke's Medical Center, where he applies his expertise in medical research and innovation. His work at this esteemed institution allows him to collaborate with other professionals in the field and contribute to groundbreaking research.

Collaborations

Throughout his career, Eisenstein has worked alongside notable colleagues such as Nino Sorgente and Klaus E. Kuettner. These collaborations have fostered an environment of innovation and have led to advancements in their respective fields.

Conclusion

Reuben Eisenstein's contributions to the field of tissue invasion inhibition exemplify the impact of innovative thinking in medical science. His patent and work at Rush-Presbyterian-St. Luke's Medical Center reflect his dedication to improving healthcare through research and collaboration.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…